Position history for Schonfeld Strategic Advisors LLC's holdings in Terns Pharmaceuticals, Inc.
Schonfeld Strategic Advisors LLC holds 754,237 shares of TERN (Terns Pharmaceuticals, Inc.), worth $30.5M as of 2025-Q4. The position was decreased (-60.1% shares). TERN represents 0.1% of Schonfeld Strategic Advisors LLC's portfolio.
Current Value
$30.5M
Current Shares
754,237
Total Value Change
+$22.6M
Total Shares Change
-441,557
Other major holders of TERN: BlackRock, Inc., MORGAN STANLEY, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, Avoro Capital Advisors LLC
Decreased |
| 754,237 |
-60.1% |
| $30.5M |
| 0.1% |
| $40.59 |
0 |
| 2025-Q3 | Decreased | 1.9M | -38.0% | $14.2M | 0.1% | $7.79 | 0 |
| 2025-Q2 | Decreased | 3M | -20.7% | $11.4M | 0.1% | $3.83 | 0 |
| 2025-Q1 | Decreased | 3.8M | -19.1% | $10.6M | 0.1% | $2.92 | 0 |
| 2024-Q4 | Increased | 4.8M | +44.4% | $26.3M | 0.2% | $5.53 | 46 |
| 2024-Q3 | Increased | 3.3M | +45.0% | $27.4M | 0.2% | $8.55 | 47 |
| 2024-Q2 | Increased | 2.3M | +89.7% | $15.4M | 0.1% | $6.81 | 44 |
| 2024-Q1 | Increased | 1.2M | +193.2% | $7.8M | 0.1% | $6.56 | 44 |